miRNA profiling of late stage metastatic Her2+ breast cancer
收藏官方服务：
资源简介：
miRNA profiling of late stage metastatic Her2+ breast cancer
应用场景：
创建时间：
2010-04-29
相关数据集
Drug screening and genomic analyses of HER2 positive breast cancer cell lines reveal predictors for treatment response [CGH]. Homo sapiens
Thirteen HER2 positive breast cancer cell lines were screened with 22 commercially available compounds, mainly targeting proteins in the ErbB2 signaling pathway, and the molecular mechanisms related t
NIAID Data Ecosystem80
BRD8 is a therapeutic vulnerability for overcoming resistance to dual ER/HER2 blockade therapy in HR+/HER2+ breast cancer
.rda file for Seurat object of scRNA-seq data from BT474 breast cancer cell lines treated with DMSO, Neratinib, Fulvestrant, and a combination of Neratinib and Fulvestrant.
Zenodo2023-05-04 更新30
miRNAs that are dysregulated in cancer tissues compared with normal controls by non-paired t-test that have rarely been mentioned in the literature.
miRNAs that are dysregulated in cancer tissues compared with normal controls by non-paired t-test that have rarely been mentioned in the literature.
Figshare2015-12-03 更新20
Identification of novel Epstein-Barr Virus miRNA genes from Nasopharyngeal Carcinomas. Homo sapiens
MicroRNAs (miRNAs) represent a conserved class of small non-coding RNAs that are found in all higher eukaryotes as well as some DNA viruses. MiRNAs are 20-25 nucleotides (nt) in length and have import
NIAID Data Ecosystem70
RNA-seq of MMTV-Neu AXL KO tumors
AXL is activated by its ligand GAS6 and is expressed in triple-negative breast cancer cells. We report that AXL is also detected in HER2+ breast cancer specimens where its expression correlates with p
NIAID Data Ecosystem30
